CoChat

In vitro metabolic zonation through oxygen gradient on a chip

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Among the multiple metabolic signals involved in the establishment of the hepatic zonation, oxygen could play a key role. Indeed, depending on hepatocyte position in the hepatic lobule, gene expression and metabolism are differently affected by the oxygen gradient present across the lobule. The aim of this study is to understand whether an oxygen gradient, generated in vitro in our developed device, is sufficient to instruct a functional metabolic zonation during the differentiation of human embryonic stem cells (hESCs) from endoderm toward terminally differentiated hepatocytes, thus mimicking the in vivo situation. For this purpose, a microfluidic device was designed for the generation of a stable oxygen gradient. The oxygen gradient was applied to differentiating hESCs at the pre-hepatoblast stage. The definitive endoderm and hepatic endoderm cells were characterized by the expression of the transcription factor SOX-17 and alpha-fetoprotein (AFP). Immature and mature hepatocytes were characterized by hepatocyte nuclear factor 4-alpha (HNF-4α) and albumin (ALB) expression and also analyzed for cytochrome P450 (CYP3A4) zonation and glycogen accumulation through PAS staining. Metabolic zonated genes expression was assessed through quantitative real time PCR. Application of the oxygen gradient during differentiation induced zonated glycogen storage, which was higher in the hepatocytes grown in high pO2 compared to those grown in low pO2. The mRNA levels of glutamine synthetase (GLUL), beta-catenin (CTNNB) and its direct target cyclin D1 (CCND1) showed significantly higher expression in the cells grown in low pO2 compared to those grown in high pO2. On the contrary, carbamoyl-phosphate synthetase 1 (CPS1), ALB, the proliferative marker ki67 (MKI67) and cyclin A (CCNA) resulted to be significantly higher expressed in cells cultured in high pO2 compared to those cultured in low pO2. These results indicate that the oxygen gradient generated in our device can instruct the establishment of a functional metabolic zonation in differentiating hESCs. The possibility to obtain differentiated hepatocytes in vitro may allow in the future to deepen our knowledge about the physiology/pathology of hepatocytes in relation to the oxygen content.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-49412-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Microfluidic chip design and oxygen gradient validation. (A) Representative image of the liver zonation generated across the hepatic lobules. Hepatocytes are naturally exposed to an oxygen gradient according to their position along the portal-central axis that allows distinguishing “periportal” from “perivenous” hepatocytes. Schematic representation of miniaturization process of the sinusoid geometry transferred to microfluidic cultures. (B) Simulation results of the steady-state oxygen concentration in the vertical cross section of the PDMS chip. Color bar shows the normalized oxygen concentration (c’) between 0 and 1. The section of cell culture and gas flow channels is also indicated. (C) Simulated steady-state profile of the scaled oxygen concentration at the bottom of the culture chamber as indicated in B, with or without cell. (D) Schematic section S1 (left) and top view (right) of the microfluidic gradient chip. Red: 95% N2/5% CO2 gas flow channels. Cyan: culture chambers. (E) Picture of the microfluidic chip filled with dyes according to the colors in D. (F) Fluorescent images of the culture chambers filled with an oxygen-sensitive ruthenium solution in PBS 1X, without gas inflowing into the gas channel (left in red) and at steady-state with nitrogen and carbon dioxide gas mixture flowing at 1 mL/min (right in blue). (G) Normalized fluorescent intensity along the culture channel cross-sections highlighted by red and blue lines in F. Red: control condition without gas flow. Blue: steady-state condition with gas flowing at 1 mL/min flow rate at the right side of the microchannel.
Figure 1 Microfluidic chip design and oxygen gradient validation. (A) Representative image of the liver zonation generated across the hepatic lobules. Hepatocytes are naturally exposed to an oxygen gradient according to their position along the portal-central axis that allows distinguishing “periportal” from “perivenous” hepatocytes. Schematic representation of miniaturization process of the sinusoid geometry transferred to microfluidic cultures. (B) Simulation results of the steady-state oxygen concentration in the vertical cross section of the PDMS chip. Color bar shows the normalized oxygen concentration (c’) between 0 and 1. The section of cell culture and gas flow channels is also indicated. (C) Simulated steady-state profile of the scaled oxygen concentration at the bottom of the culture chamber as indicated in B, with or without cell. (D) Schematic section S1 (left) and top view (right) of the microfluidic gradient chip. Red: 95% N2/5% CO2 gas flow channels. Cyan: culture chambers. (E) Picture of the microfluidic chip filled with dyes according to the colors in D. (F) Fluorescent images of the culture chambers filled with an oxygen-sensitive ruthenium solution in PBS 1X, without gas inflowing into the gas channel (left in red) and at steady-state with nitrogen and carbon dioxide gas mixture flowing at 1 mL/min (right in blue). (G) Normalized fluorescent intensity along the culture channel cross-sections highlighted by red and blue lines in F. Red: control condition without gas flow. Blue: steady-state condition with gas flowing at 1 mL/min flow rate at the right side of the microchannel.CC BY · PubMed Central
Figure 2 Characterization of hESCs (MShef-3 line) hepatic differentiation into a microfluidic chip. (A) Cells showing SOX-17 (green) at day 5, alpha-fetoprotein (green) at day 8, HNF-4α (red) and alpha-fetoprotein (green) at day 13, albumin (red) and f-actin (green) at day 17 of differentiation. Scale bars 200 μm (microchannel) and 20 μm (inset). (B) Live/Dead assay showing high (left) and low (right) O2 differentiated hESCs at day 12 in microfluidic chips (3 parallel channels above, with enlargement below). Cell nuclei counterstained with Hoechst in blue, dead cells stained in red with ethidium homodimer-1, living cells fluorescence in green with calcein AM. Scale bars 300 μm (microchannels, above) and 10 μm (enlargement, below). (C) Day 13 differentiated hESCs showing HNF-4α (red) and alpha-fetoprotein (green), in high (above) and low (below) O2 differentiation experiments. Scale bars 100 μm (microchannel) and 50 μm (inset).
Figure 2 Characterization of hESCs (MShef-3 line) hepatic differentiation into a microfluidic chip. (A) Cells showing SOX-17 (green) at day 5, alpha-fetoprotein (green) at day 8, HNF-4α (red) and alpha-fetoprotein (green) at day 13, albumin (red) and f-actin (green) at day 17 of differentiation. Scale bars 200 μm (microchannel) and 20 μm (inset). (B) Live/Dead assay showing high (left) and low (right) O2 differentiated hESCs at day 12 in microfluidic chips (3 parallel channels above, with enlargement below). Cell nuclei counterstained with Hoechst in blue, dead cells stained in red with ethidium homodimer-1, living cells fluorescence in green with calcein AM. Scale bars 300 μm (microchannels, above) and 10 μm (enlargement, below). (C) Day 13 differentiated hESCs showing HNF-4α (red) and alpha-fetoprotein (green), in high (above) and low (below) O2 differentiation experiments. Scale bars 100 μm (microchannel) and 50 μm (inset).CC BY · PubMed Central
Figure 3 Liver zonation and hepatic glycogen storage evaluation. (A) Microfluidic differentiated (HES2 line) hepatocyte under constant oxygen gradient at day 17 of differentiation. Nuclear counterstain with Hoechst (blue) and f-actin staining (green). Scale bar 300 µm. (B) CYP3A4 (red) staining with representative images of day 17 differentiated hepatocytes across the gradient microchannel. Scale bar 20 µm. (C) Relative fluorescence unit plot of ROI in gradient microchannels and control microchannels (high O2 differentiation). Data are expressed as mean ± SD (n > 10) and trend line. (D) Example of automated recognition of Periodic Acid-Shiff (PAS+) areas in images taken after PAS staining of hepatocyte-like cells, without or with diastase (indicated with D) treatment. (E) Representative color images of PAS staining in hepatocyte-like cells grown in control and O2 gradient chip (with enlargement inset), respectively. Scale bar 100 µm. (F) Quantification of PAS+ areas in images obtained from the control and O2 gradient chip, shown in E. Data were acquired from the central part of the channel to the borders. Data are expressed as mean ± SD (n > 9). *Student’s t-test p < 0.05.
Figure 3 Liver zonation and hepatic glycogen storage evaluation. (A) Microfluidic differentiated (HES2 line) hepatocyte under constant oxygen gradient at day 17 of differentiation. Nuclear counterstain with Hoechst (blue) and f-actin staining (green). Scale bar 300 µm. (B) CYP3A4 (red) staining with representative images of day 17 differentiated hepatocytes across the gradient microchannel. Scale bar 20 µm. (C) Relative fluorescence unit plot of ROI in gradient microchannels and control microchannels (high O2 differentiation). Data are expressed as mean ± SD (n > 10) and trend line. (D) Example of automated recognition of Periodic Acid-Shiff (PAS+) areas in images taken after PAS staining of hepatocyte-like cells, without or with diastase (indicated with D) treatment. (E) Representative color images of PAS staining in hepatocyte-like cells grown in control and O2 gradient chip (with enlargement inset), respectively. Scale bar 100 µm. (F) Quantification of PAS+ areas in images obtained from the control and O2 gradient chip, shown in E. Data were acquired from the central part of the channel to the borders. Data are expressed as mean ± SD (n > 9). *Student’s t-test p < 0.05.CC BY · PubMed Central
Figure 4 Gene expression analysis in hepatocyte-like cells (HES2 line). In all panels, the levels of the target mRNA are normalized to the expression level of the 28S rRNA. (A) Real-time PCR of genes involved in metabolic and cell cycle processes in hepatocyte-like cells obtained following hESCs differentiation at uniform 21% O2 concentration (control chip). No statistical difference is observed between the right side and the left side. Data, normalized to the average of the right side, are shown as mean ± SEM. n = 3. Real-time PCR of genes involved in metabolic and cell cycle processes in hepatocyte-like cells grown in a stable O2 gradient generated by the microfluidic device. (B) GLUL (glutamine synthetase), CTNNB (beta-catenin) and CCND1 (cyclin D1) show significantly higher expression in low pO2. (C) CPS-1 (carbamoyl-phosphate synthetase 1), ALB (albumin), MKI67, CCNA (cyclin A) show significantly higher expression in high pO2. Data, normalized to the average of 21% O2, are shown as mean ± SEM. n = 9. p* < 0.001 and p§ < 0.0001 respect to 21% O2.
Figure 4 Gene expression analysis in hepatocyte-like cells (HES2 line). In all panels, the levels of the target mRNA are normalized to the expression level of the 28S rRNA. (A) Real-time PCR of genes involved in metabolic and cell cycle processes in hepatocyte-like cells obtained following hESCs differentiation at uniform 21% O2 concentration (control chip). No statistical difference is observed between the right side and the left side. Data, normalized to the average of the right side, are shown as mean ± SEM. n = 3. Real-time PCR of genes involved in metabolic and cell cycle processes in hepatocyte-like cells grown in a stable O2 gradient generated by the microfluidic device. (B) GLUL (glutamine synthetase), CTNNB (beta-catenin) and CCND1 (cyclin D1) show significantly higher expression in low pO2. (C) CPS-1 (carbamoyl-phosphate synthetase 1), ALB (albumin), MKI67, CCNA (cyclin A) show significantly higher expression in high pO2. Data, normalized to the average of 21% O2, are shown as mean ± SEM. n = 9. p* < 0.001 and p§ < 0.0001 respect to 21% O2.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 1

  1. Stern OaV O. The extinction period of fluorescence Phys. Z 1919 20 183 188

Cited by

See all 81

Metadata

Authors
Tonon, F., Giobbe, G. G., Zambon, A., Luni, C., Gagliano, O., Floreani, A., Grassi, G., & Elvassore, N.
Affiliations
  • University of Trieste (IT)
  • University of Padua (IT)
  • ShanghaiTech University (CN)
Corresponding author
Elvassore, Nicola
Venue
Scientific Reports
Published
2019-09-19
Volume
9
Issue
1
Pages
13557-13557
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2974497812
Cited by
76
References
29
Citations by year
2026: 5 · 2025: 11 · 2024: 8 · 2023: 16 · 2022: 15 · 2021: 12 · 2020: 8
FWCI
5.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
  • Oak Foundation (W1095/OCAY-14-191)
  • Universit&amp;#x00E0; degli Studi di Padova (TRANSAC, PRAT)
  • Fondazione Telethon (GGP15275)
  • Fondazione Cassa di Risparmio di Padova e Rovigo
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
hepatic zonation, oxygen gradients, microfluidics, human embryonic stem cells, hepatocyte differentiation, glycogen accumulation, CYP3A4, glutamine synthetase, β-catenin, cyclin D1, HNF4α, SOX17, alpha-fetoprotein
MeSH terms
alpha-Fetoproteins, Cell Differentiation, Cell Line, Humans, Oxygen, Cell Culture Techniques, Gene Expression Profiling, Hepatocytes, Microfluidic Analytical Techniques, Cell Proliferation, Hepatocyte Nuclear Factor 4, Embryonic Stem Cells, SOXF Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro metabolic zonation through oxygen gradient on a chip. https://app.cochat.ai/papers/10.1038/s41598-019-49412-6
The paper
Tonon, F., Giobbe, G. G., Zambon, A., Luni, C., Gagliano, O., Floreani, A., Grassi, G., & Elvassore, N. (2019). In vitro metabolic zonation through oxygen gradient on a chip. Scientific Reports. https://doi.org/10.1038/s41598-019-49412-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.